Skip to main content
Top
Published in: Diabetologia 3/2007

01-03-2007 | Research Letter

How much insulin is enough? A quantitative assessment of the transdifferentiaton potential of liver

Authors: S. Perl, B. Hirshberg, D. M. Harlan, J. F. Tisdale

Published in: Diabetologia | Issue 3/2007

Login to get access

Excerpt

Adenoviral vector-mediated expression of the pancreatic and duodenal homeobox 1 gene (Pdx1; current designation in mice insulin promotor factor-1, Ipf1) in mice has previously been reported to result in hepatic, glucose-regulated insulin secretion sufficient to ameliorate experimentally induced diabetes [1]. In studies designed to assess the clinical applicability of this approach, we developed a protocol employing non-human primates rendered insulin-deficient (and therefore diabetic) through selective intra-arterial streptozotocin (STZ) infusion into the pancreas [2]. We obtained and amplified the adenoviral vector in which the CMV promoter drives rat Pdx1 expression (Ad-CMV-Pdx1 referred to hereafter as Ad-Pdx1), kindly provided by S. Ferber, Endocrine Institute, Sheba Medical Centre, Tel-Hashomer, Israel. …
Literature
1.
go back to reference Ferber S, Halkin A, Cohen H et al (2000) Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 6:568–572PubMedCrossRef Ferber S, Halkin A, Cohen H et al (2000) Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 6:568–572PubMedCrossRef
2.
go back to reference Tal MG, Hirshberg B, Neeman Z et al (2004) Induction of diabetes in nonhuman primates by means of temporary arterial embolization and selective arterial injection of streptozotocin. Radiology 230:163–168PubMed Tal MG, Hirshberg B, Neeman Z et al (2004) Induction of diabetes in nonhuman primates by means of temporary arterial embolization and selective arterial injection of streptozotocin. Radiology 230:163–168PubMed
3.
go back to reference Ber I, Shternhall K, Perl S et al (2003) Functional, persistent, and extended liver to pancreas transdifferentiation. J Biol Chem 278:31950–31957PubMedCrossRef Ber I, Shternhall K, Perl S et al (2003) Functional, persistent, and extended liver to pancreas transdifferentiation. J Biol Chem 278:31950–31957PubMedCrossRef
4.
go back to reference Feudtner JC (2003) Bittersweet: diabetes, insulin, and the transformation of illness, vol 2. University of North Carolina Press, Chapel Hill Feudtner JC (2003) Bittersweet: diabetes, insulin, and the transformation of illness, vol 2. University of North Carolina Press, Chapel Hill
5.
go back to reference Kojima H, Fujimiya M, Matsumura K et al (2004) Extrapancreatic insulin-producing cells in multiple organs in diabetes. Proc Natl Acad Sci USA 101:2458–2463PubMedCrossRef Kojima H, Fujimiya M, Matsumura K et al (2004) Extrapancreatic insulin-producing cells in multiple organs in diabetes. Proc Natl Acad Sci USA 101:2458–2463PubMedCrossRef
6.
go back to reference Rajagopal J, Anderson WJ, Kume S et al (2003) Insulin staining of ES cell progeny from insulin uptake. Science 299:363PubMed Rajagopal J, Anderson WJ, Kume S et al (2003) Insulin staining of ES cell progeny from insulin uptake. Science 299:363PubMed
Metadata
Title
How much insulin is enough? A quantitative assessment of the transdifferentiaton potential of liver
Authors
S. Perl
B. Hirshberg
D. M. Harlan
J. F. Tisdale
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 3/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0549-0

Other articles of this Issue 3/2007

Diabetologia 3/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.